aid: granzabio accessModel: pricing: unknown onboarding: unknown trial: false try_now: false public: false label: Unknown confidence: low source: [] generated: '2026-07-22' method: derived image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/granzabio.png name: Granza Bio description: >- Granza Bio is an early-stage biotechnology company reprogramming immunity for target-specific medicines. Founded in 2024 by Dr. Ashwin Nandakumar, Dr. Ashwin Jainarayanan, and Prof. Michael Dustin, the company builds on the discovery of "attack particles" — killing entities released by cytotoxic immune cells, characterized in Prof. Dustin's laboratory at the University of Oxford. Granza Bio is developing an engineered delivery-shell platform that directs therapeutic cargo to specific tissues, with the goal of advancing treatments for cancers, autoimmune disorders, and infections. The company raised $7.14M in seed funding co-led by Refactor Capital and Felicis, with participation from Pioneer Fund and Y Combinator. It is a research-stage life-sciences company and does not currently publish a public developer API, SDK, or developer portal; this profile is maintained in the API Evangelist network as a company record. url: https://raw.githubusercontent.com/api-evangelist/granzabio/refs/heads/main/apis.yml x-type: company x-source: vc-portfolio x-backed-by: - felicis x-tier: stub x-tier-reason: portfolio-lead specificationVersion: '0.20' created: '2026-07-17' modified: '2026-07-19' tags: - Company - Biotechnology - Immunotherapy - Drug Delivery - Life Sciences - Oncology - Therapeutics apis: [] maintainers: - FN: Kin Lane email: kin@apievangelist.com - FN: APIs.json email: info@apis.io common: - type: Website url: https://granzabio.com - type: Blog name: Newsroom url: https://www.granzabio.com/newsroom - type: PrivacyPolicy url: https://www.granzabio.com/privacy-policy - type: DomainSecurity url: security/granzabio-domain-security.yml x-enrichment: date: '2026-07-19' status: backfilled pass: local-v1 note: backfilled from .gitignore signal + verified work evidence